The Rate, Pattern, and Cost of Use of Antiparkinsonian Agents Among Patients Treated for Schizophrenia in a Managed Care SettingByHaya Ascher-Svanum, PhD,John S. Kennedy, MD,David Lee, PhD,Merle Haberman, MHAJanuary 1st 2004
Employee Responses to Health Insurance Premium IncreasesByDana P. Goldman, PhD,Arleen A. Leibowitz, PhD,David A. Robalino, PhDJanuary 1st 2004
Determinants of Hospital Length of Stay for Cervical Dysplasia and Cervical Cancer: Does Managed Care Matter?ByGregory D. Berg, PhD,Sajal K. Chattopadhyay, PhDJanuary 1st 2004
Asthma Population Management: Development and Validation of a Practical 3-Level Risk Stratification SchemeByMichael Schatz, MD, MS,Randy Nakahiro, PharmD,Christine H. Jones, RN, MBAJanuary 1st 2004
Integration of Clinical Practice, Publicity, and Policy: A Shot in the Arm for Influenza ControlByKevin P. Cain, MD,Susan G. Blitz, MD, MPHJanuary 1st 2004
The Physician's Office: Can It Influence Adult Immunization Rates?ByMary Patricia Nowalk, PhD,Inis Jane Bardella, MD,Richard Kent Zimmerman, MD,Shunhua Shen, MSJanuary 1st 2004
